Literature DB >> 7019079

Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice.

K Matsumoto, H Ogawa, T Kusama, O Nagase, N Sawaki, M Inage, S Kusumoto, T Shiba, I Azuma.   

Abstract

The experimental system utilized in investigating the correlation between the chemical structures of muramyl peptides and their protective activities in the sepsis type of systemic infections caused by Escherichia coli was applied in evaluating the enhancement of resistance to infection induced by 32 synthetic glycopeptide analogs, including 6-O-acyl derivatives and 1-alpha-O-benzyl derivatives of muramyl dipeptide (N-acetyl muramyl-L-alanyl-D-isoglutamine). In assessing the 6-O-acyl derivatives of muramyl dipeptide, we found that the degree of protective activity was attributable to the kinds of fatty acids introduced. Acylation of the 6-hydroxy group on the muramic acid moiety in muramyl dipeptide with natural mycolic acid or a synthetic fatty acid possessing either an alpha-branched or an alpha-branched, beta-hydroxylated group resulted in a decrease in or a disappearance of the protective activity of muramyl dipeptide. Acylation with a normal fatty acid or an iso fatty acid resulted in a retention or enhancement of muramyl dipeptide activity. The activity of acylated derivatives containing linear fatty acids was stimulated by increasing the chain length up to 18 carbon atoms. The highest degree of protective activity occurred with the derivatives acylated with straight-chain fatty acids, particularly with the derivatives acylated with palmitic acid and arachidic acid. Benzylation of the 1-hydroxy group of muramyl dipeptide resulted in a decrease in or a loss of protective activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7019079      PMCID: PMC351510          DOI: 10.1128/iai.32.2.748-758.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Immunoadjuvant activities of peptidoglycan subunits from the cell walls of Staphyloccus aureus and Lactobacillus plantarum.

Authors:  S Kotani; Y Watanabe; T Shimono; F Kinoshita; T Narita
Journal:  Biken J       Date:  1975-06

2.  Modulation of the immune response by a synthetic adjuvant and analogs.

Authors:  L Chedid; F Audibert; P Lefrancier; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

3.  Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  C Merser; P Sinay; A Adam
Journal:  Biochem Biophys Res Commun       Date:  1975-10-27       Impact factor: 3.575

4.  Adjuvant activity of synthetic cell-wall peptidoglycan subunits on monoazobenzenearsonate-N-acetyl-L-tyrosine and bacterial alpha-amylase in guinea pigs.

Authors:  I Azuma; K Sugimura; Y Yamamura; S Kusumoto; Y Tarumi
Journal:  Jpn J Microbiol       Date:  1976-02

5.  Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers.

Authors:  A Adam; M Devys; V Souvannavong; P Lefrancier; J Choay; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1976-09-07       Impact factor: 3.575

6.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

7.  Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plant arum and analogous synthetic compounds.

Authors:  O Kohashi; C M Pearson; Y Watanabe; S Kotani; T Koga
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

8.  Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; T Shimono; K Harada; T Shiba
Journal:  Biken J       Date:  1976-03

9.  Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.

Authors:  I Azuma; K Sugimura; T Taniyama; M Yamawaki; Y Yamamura
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

10.  Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; F Kinoshita; T Shimono; I Morisaki
Journal:  Biken J       Date:  1975-06
View more
  18 in total

1.  Synergistic effects of romurtide and cefmenoxime against experimental Klebsiella pneumonia in mice.

Authors:  O Tatara; C Nakahama; Y Niki
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.

Authors:  Y Osada; M Mitsuyama; K Matsumoto; T Une; T Otani; H Ogawa; K Nomoto
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

3.  Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18).

Authors:  M Akasaki; T Takashi; Y Kita; W Tsukada
Journal:  Agents Actions       Date:  1987-10

4.  Augmentation of protective and antibacterial activity induced by muramyl dipeptides in CBA/N defective mice with X-linked immunodeficiency for Salmonella enteritidis infection.

Authors:  K Onozuka; T Saito-Taki; M Nakano
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

5.  Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog.

Authors:  Y Osada; T Otani; M Sato; T Une; K Matsumoto; H Ogawa
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

6.  Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer.

Authors:  Xuqin Li; Junli Yu; Song Xu; Nan Wang; Hongzhen Yang; Zheng Yan; Guifang Cheng; Gang Liu
Journal:  Glycoconj J       Date:  2007-12-27       Impact factor: 2.916

7.  Uveitis induction in the rabbit by muramyl dipeptides.

Authors:  R V Waters; T G Terrell; G H Jones
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

Review 8.  Molecular adjuvants and immunomodulators: new approaches to immunization.

Authors:  A G Johnson
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

9.  Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxin.

Authors:  N Bloksma; F M Hofhuis; J M Willers
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

10.  Stimulation of chemiluminescence by synthetic muramyl dipeptide and analogs.

Authors:  K N Masihi; I Azuma; W Brehmer; W Lange
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.